These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297 [TBL] [Abstract][Full Text] [Related]
25. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma. Wang RH World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094 [TBL] [Abstract][Full Text] [Related]
26. Elevated expression of the ornithine decarboxylase gene in human esophageal cancer. Yoshida M; Hayashi H; Taira M; Isono K Cancer Res; 1992 Dec; 52(23):6671-5. PubMed ID: 1423312 [TBL] [Abstract][Full Text] [Related]
27. Esophageal biopsy in the diagnosis of reflux esophagitis. Leape LL; Bhan I; Ramenofsky ML J Pediatr Surg; 1981 Jun; 16(3):379-84. PubMed ID: 7252745 [TBL] [Abstract][Full Text] [Related]
28. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656 [TBL] [Abstract][Full Text] [Related]
35. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities. Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517 [TBL] [Abstract][Full Text] [Related]
36. Barrett's esophagus in patients with symptomatic reflux esophagitis. Mann NS; Tsai MF; Nair PK Am J Gastroenterol; 1989 Dec; 84(12):1494-6. PubMed ID: 2596449 [TBL] [Abstract][Full Text] [Related]
37. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456 [TBL] [Abstract][Full Text] [Related]
38. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Kauer WK; Peters JH; DeMeester TR; Ireland AP; Bremner CG; Hagen JA Ann Surg; 1995 Oct; 222(4):525-31; discussion 531-3. PubMed ID: 7574932 [TBL] [Abstract][Full Text] [Related]
39. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines. Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985 [TBL] [Abstract][Full Text] [Related]
40. Duodeno-gastric-esophageal reflux--what is pathologic? Comparison of patients with Barrett's esophagus and age-matched volunteers. Wolfgarten E; Pütz B; Hölscher AH; Bollschweiler E J Gastrointest Surg; 2007 Apr; 11(4):479-86. PubMed ID: 17436133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]